Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 914

PubMed for Gene (Select 2033)

1.

The PHD finger of p300 influences its ability to acetylate histone and non-histone targets.

Rack JG, Lutter T, Kjæreng Bjerga GE, Guder C, Ehrhardt C, Värv S, Ziegler M, Aasland R.

J Mol Biol. 2014 Dec 12;426(24):3960-72. doi: 10.1016/j.jmb.2014.08.011. Epub 2014 Aug 23.

PMID:
25158095
2.

Naphthoquinone-mediated inhibition of lysine acetyltransferase KAT3B/p300, basis for non-toxic inhibitor synthesis.

Vasudevarao MD, Mizar P, Kumari S, Mandal S, Siddhanta S, Swamy MM, Kaypee S, Kodihalli RC, Banerjee A, Naryana C, Dasgupta D, Kundu TK.

J Biol Chem. 2014 Mar 14;289(11):7702-17. doi: 10.1074/jbc.M113.486522. Epub 2014 Jan 27.

3.

Prognostic impact of p300 expression in patients with colorectal cancer.

Huh JW, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Chun HK.

J Surg Oncol. 2013 Nov;108(6):374-7. doi: 10.1002/jso.23405. Epub 2013 Sep 23.

PMID:
24142575
4.

Charge density distribution and the electrostatic moments of CTPB in the active site of p300 enzyme: a DFT and charge density study.

Devipriya B, Kumaradhas P.

J Theor Biol. 2013 Oct 21;335:119-29. doi: 10.1016/j.jtbi.2013.06.001. Epub 2013 Jun 13.

PMID:
23770402
5.

Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability.

Kim MS, Lee SH, Yoo NJ, Lee SH.

Hum Pathol. 2013 Oct;44(10):2064-70. doi: 10.1016/j.humpath.2012.11.027. Epub 2013 Jun 4.

PMID:
23759652
6.

p300/CBP dependent hyperacetylation of histone potentiates anticancer activity of gefitinib nanoparticles.

Kaur J, Tikoo K.

Biochim Biophys Acta. 2013 May;1833(5):1028-40. doi: 10.1016/j.bbamcr.2013.01.029. Epub 2013 Feb 4.

7.
8.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
9.

A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT.

Martín-Antonio B, Álvarez-Laderas I, Cardesa R, Márquez-Malaver F, Baez A, Carmona M, Falantes J, Suarez-Lledo M, Fernández-Avilés F, Martínez C, Rovira M, Espigado I, Urbano-Ispizua Á.

Bone Marrow Transplant. 2012 Sep;47(9):1206-11. doi: 10.1038/bmt.2011.253. Epub 2012 Jan 9.

PMID:
22231458
10.

The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300.

Shames SR, Bhavsar AP, Croxen MA, Law RJ, Mak SH, Deng W, Li Y, Bidshari R, de Hoog CL, Foster LJ, Finlay BB.

Cell Microbiol. 2011 Oct;13(10):1542-57. doi: 10.1111/j.1462-5822.2011.01640.x. Epub 2011 Aug 4.

PMID:
21812888
11.

High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells.

Yokomizo C, Yamaguchi K, Itoh Y, Nishimura T, Umemura A, Minami M, Yasui K, Mitsuyoshi H, Fujii H, Tochiki N, Nakajima T, Okanoue T, Yoshikawa T.

Cancer Lett. 2011 Nov 28;310(2):140-7. doi: 10.1016/j.canlet.2011.06.030. Epub 2011 Jul 1.

PMID:
21764211
12.

High expression of p300 has an unfavorable impact on survival in resectable esophageal squamous cell carcinoma.

Li Y, Yang HX, Luo RZ, Zhang Y, Li M, Wang X, Jia WH.

Ann Thorac Surg. 2011 May;91(5):1531-8. doi: 10.1016/j.athoracsur.2010.12.012.

PMID:
21524463
13.

p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.

Panicker SP, Raychaudhuri B, Sharma P, Tipps R, Mazumdar T, Mal AK, Palomo JM, Vogelbaum MA, Haque SJ.

Oncotarget. 2010 Aug;1(4):289-303.

14.

A rearranged EP300 gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity.

Garbati MR, Thompson RC, Haery L, Gilmore TD.

Cancer Lett. 2011 Mar 1;302(1):76-83. doi: 10.1016/j.canlet.2010.12.018. Epub 2011 Jan 12. Erratum in: Cancer Lett. 2012 Feb 1;315(1):96.

15.

High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.

Li M, Luo RZ, Chen JW, Cao Y, Lu JB, He JH, Wu QL, Cai MY.

J Transl Med. 2011 Jan 5;9:5. doi: 10.1186/1479-5876-9-5.

16.

Activator-dependent p300 acetylation of chromatin in vitro: enhancement of transcription by disruption of repressive nucleosome-nucleosome interactions.

Szerlong HJ, Prenni JE, Nyborg JK, Hansen JC.

J Biol Chem. 2010 Oct 15;285(42):31954-64. doi: 10.1074/jbc.M110.148718. Epub 2010 Aug 18.

17.

p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals.

Vempati RK, Jayani RS, Notani D, Sengupta A, Galande S, Haldar D.

J Biol Chem. 2010 Sep 10;285(37):28553-64. doi: 10.1074/jbc.M110.149393. Epub 2010 Jun 29.

18.

Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes.

Chen J, Ghazawi FM, Li Q.

Epigenetics. 2010 Aug 16;5(6):509-15. Epub 2010 Aug 16.

19.

Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome.

Bartsch O, Labonté J, Albrecht B, Wieczorek D, Lechno S, Zechner U, Haaf T.

Am J Med Genet A. 2010 Jan;152A(1):181-4. doi: 10.1002/ajmg.a.33153.

PMID:
20014264
20.

Structure of the Taz2 domain of p300: insights into ligand binding.

Miller M, Dauter Z, Cherry S, Tropea JE, Wlodawer A.

Acta Crystallogr D Biol Crystallogr. 2009 Dec;65(Pt 12):1301-8. doi: 10.1107/S0907444909040153. Epub 2009 Nov 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk